Clinical Trial Update: The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating SHR-1316 (adebrelimab) plus platinum-containing doublet induction therapy followed by surgery and radiotherapy for limited-stage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• SHR-1316 (adebrelimab) (adebrelimab)
• platinum-containing doublet induction therapy

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Limited Stage Small Cell Lung Cancer | Phase 3 | Status: NOT_YET_RECRUITING